Market Research Logo

Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review

Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, OLED materials and cosmetic active ingredients. The company also provides a wide range of products including lab water systems to gene editing tools, cell lines, antibodies and end-to-end systems. Merck serves healthcare, performance materials and life sciences markets. It has presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.

Merck KGaA Key Recent Developments

Apr 05,2018: Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry
Apr 04,2018: MilliporeSigma to Launch New Flow Cytometer, Host CellStream Workshop at CYTO 2018
Mar 29,2018: Merck Showcases New Innovations at INTERPHEX 2018
Mar 26,2018: ITRI Collaborates with Merck to Enhance New Drug Manufacturing
Mar 20,2018: Merck KGaA, Darmstadt, Germany to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 22nd March 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Merck KGaA - Key Facts
Merck KGaA - Key Employees
Merck KGaA - Key Employee Biographies
Merck KGaA - Key Operational Employees
Merck KGaA - Major Products and Services
Merck KGaA - History
Merck KGaA - Company Statement
Merck KGaA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Merck KGaA - Business Description
Business Segment: Healthcare
Overview
Performance
Business Segment: Life ­Science
Performance
Business Segment: Life Science
Overview
Key Stats
Business Segment: Performance Materials
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: Middle East and Africa
Performance
Geographical Segment: North America
Performance
R&D Overview
Merck KGaA - Corporate Strategy
Merck KGaA - SWOT Analysis
SWOT Analysis - Overview
Merck KGaA - Strengths
Merck KGaA - Weaknesses
Merck KGaA - Opportunities
Merck KGaA - Threats
Merck KGaA - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Merck KGaA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 05, 2018: Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry
Apr 04, 2018: MilliporeSigma to Launch New Flow Cytometer, Host CellStream Workshop at CYTO 2018
Mar 29, 2018: Merck Showcases New Innovations at INTERPHEX 2018
Mar 26, 2018: ITRI Collaborates with Merck to Enhance New Drug Manufacturing
Mar 20, 2018: Merck KGaA, Darmstadt, Germany to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 22nd March 2018
Mar 19, 2018: The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the ‘Lab of the Future’
Mar 01, 2018: Merck to Present New Data from Studies of Investigational HIV Therapies Doravirine and MK-8591 at CROI 2018
Feb 23, 2018: Fish & Richardson Wipes Out $2.5 Billion Patent Verdict Against Gilead Sciences on JMOL
Feb 21, 2018: Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia
Feb 20, 2018: Merck Receives Two More Patents for CRISPR Technology
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Merck KGaA, Key Facts
Merck KGaA, Key Employees
Merck KGaA, Key Employee Biographies
Merck KGaA, Key Operational Employees
Merck KGaA, Major Products and Services
Merck KGaA, History
Merck KGaA, Subsidiaries
Merck KGaA, Key Competitors
Merck KGaA, Ratios based on current share price
Merck KGaA, Annual Ratios
Merck KGaA, Annual Ratios (Cont...1)
Merck KGaA, Annual Ratios (Cont...2)
Merck KGaA, Interim Ratios
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Merck KGaA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Merck KGaA, Performance Chart (2013 - 2017)
Merck KGaA, Ratio Charts
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Merck KGaA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report